Marcello PERSICO
Marcello PERSICO
Professore Associato Medicina Interna Università di Salerno
Email verificata su
TitoloCitata daAnno
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3
A Mangia, R Santoro, N Minerva, GL Ricci, V Carretta, M Persico, F Vinelli, ...
New England Journal of Medicine 352 (25), 2609-2617, 2005
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study
S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ...
Hepatology 45 (3), 579-587, 2007
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis
B Palmentieri, I De Sio, V La Mura, M Masarone, R Vecchione, S Bruno, ...
Digestive and Liver Disease 38 (7), 485-489, 2006
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
M Persico, E Persico, R Suozzo, S Conte, M de Seta, L Coppola, ...
Gastroenterology 118 (4), 760-764, 2000
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert …
P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ...
Digestive and Liver Disease 42 (4), 272-282, 2010
Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study
GD De Palma, A Pezzullo, M Rega, M Persico, F Patrone, L Mastantuono, ...
Gastrointestinal endoscopy 58 (1), 50-53, 2003
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment
E Gane, E Lawitz, D Pugatch, G Papatheodoridis, N Bräu, A Brown, S Pol, ...
New England Journal of Medicine 377 (15), 1448-1455, 2017
Non alcoholic fatty liver: epidemiology and natural history
M Masarone, A Federico, L Abenavoli, C Loguercio, M Persico
Reviews on recent clinical trials 9 (3), 126-133, 2014
Synthesis of N1-arylidene-N2-quinolyl-and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains
S Gemma, G Kukreja, C Fattorusso, M Persico, MP Romano, M Altarelli, ...
Bioorganic & medicinal chemistry letters 16 (20), 5384-5388, 2006
Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial
S Bruno, P Maisonneuve, P Castellana, N Rotmensz, S Rossi, ...
bmj 330 (7497), 932, 2005
Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus–related chronic hepatitis: insulin resistance and response to antiviral therapy
M Persico, M Capasso, E Persico, M Svelto, R Russo, D Spano, L Crocè, ...
Hepatology 46 (4), 1009-1015, 2007
Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77
C Ferlini, L Cicchillitti, G Raspaglio, S Bartollino, S Cimitan, C Bertucci, ...
Cancer research 69 (17), 6906-6914, 2009
Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial
CLIP Group
The Lancet 352 (9121), 17-20, 1998
Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus–infected patients treated for non-Hodgkin lymphoma
M Persico, F De Marino, GDG Russo, A Severino, B Palmentieri, M Picardi, ...
Blood 99 (2), 724-725, 2002
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C
M Persico, M Capasso, R Russo, E Persico, L Croce, C Tiribelli, ...
Gut 57 (4), 507-515, 2008
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover …
FC Sasso, O Carbonara, M Persico, D Iafusco, T Salvatore, R D’Ambrosio, ...
Diabetes Care 25 (11), 1909-1913, 2002
Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663
G Maga, S Gemma, C Fattorusso, GA Locatelli, S Butini, M Persico, ...
Biochemistry 44 (28), 9637-9644, 2005
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus–related chronic hepatitis, cirrhosis, and hepatocellular carcinoma
G Nardone, M Romano, A Calabro, PV Pedone, I de Sio, M Persico, ...
Hepatology 23 (6), 1304-1312, 1996
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin’s lymphoma
V La Mura, A De Renzo, F Perna, D D’Agostino, M Masarone, M Romano, ...
Journal of hepatology 49 (4), 557-563, 2008
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of …
G Campiani, C Fattorusso, S Butini, A Gaeta, M Agnusdei, S Gemma, ...
Journal of medicinal chemistry 48 (6), 1919-1929, 2005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20